Skip to main content
OpenTrials

Clinical trial condition

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Explore clinical trials studying Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Study availability and eligibility vary by location and protocol.

23 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Chronic Inflammatory Demyelinating Polyradiculoneuropathy trial results

Completed

Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT04658472

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • University of Southern California Site Number : 8400004 Los Angeles, California, United States
  • University of California Irvine Site Number : 8400002 Orange, California, United States
  • The University of Kansas Clinical Research Center Site Number : 8400003 Fairway, Kansas, United States
  • University of Minnesota Site Number : 8400006 Minneapolis, Minnesota, United States
View all 32 locations
View Trial Details
Completed

Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP

NCT02955355

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Arizona Neuromuscular Research Center Phoenix, Arizona, United States
  • Hosp.Britanico de Buenos Aires Ciudad Autonoma Buenos Aires, Argentina
  • Instituto de Neurologia de Curitiba - Hospital Ecoville Curitiba, Paraná, Brazil
  • University of Alberta Hospital Edmonton, Alberta, Canada
View all 35 locations
View Trial Details
Completed

A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT02549170

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Arizona Neuromuscular Research Center Phoenix, Arizona, United States
  • HonorHealth Neurology Scottsdale, Arizona, United States
  • University of California-Irvine Orange, California, United States
View all 83 locations
View Trial Details
Completed

Efficacy and Safety Study of I10E in Treatment of Patients With CIDP

NCT02293460

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • CHU de Bordeaux - Hôpital Pellegrin Bordeaux, France
  • Hôpital général du CHU de Dijon Dijon, France
  • CHU de Nice - Hôpital l'Archet Nice, France
  • CHU Paris - Hôpital Pitié salpétrière Paris, France
View all 33 locations
View Trial Details
Completed

Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.

NCT01625182

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Novartis Investigative Site Orange, California, United States
  • Novartis Investigative Site Miami, Florida, United States
  • Novartis Investigative Site St. Petersburg, Florida, United States
  • Novartis Investigative Site Chicago, Illinois, United States
View all 67 locations
View Trial Details

Related conditions